Orange Book product · Generic (ANDA)
CEFOTAXIME SODIUM
CEFOTAXIME SODIUM
At a glance
Aug 11, 2006
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 11, 2006
20 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFOTAXIME SODIUM
Strength
EQ 1GM BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 065290
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEFOTAXIME SODIUM
- 2004CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINERBrand (NDA)
NDA 050792 · B BRAUN
- 1985CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINERBrand (NDA)
NDA 050596 · STERIMAX
- —CLAFORANBrand (NDA)
NDA 050547 · STERIMAX
- 2016CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 203132 · HOSPIRA
- 2010CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065348 · CEPHAZONE PHARMA
- 2009CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065517 · AUROBINDO PHARMA
- 2009CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065516 · AUROBINDO PHARMA LTD
- 2006CEFOTAXIMEGeneric (ANDA)
ANDA 065197 · WOCKHARDT
- 2006CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065293 · HOSPIRA INC
- 2006CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065292 · HOSPIRA INC
- 2003CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065124 · LUPIN
- 2002CEFOTAXIMEGeneric (ANDA)
ANDA 065072 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
